Vyome Holdings HIND
NASDAQ HIND
$1.89 -0.03 (-1.80%)
As of: Oct 2, 2026 · 1:05 PM EDT

Vyome Holdings (HIND) Depreciation & Amortization (CF) (2015 - 2026)

Updated

Vyome Holdings' Depreciation & Amortization (CF) came in at $2,610 for Q2 2026, down 12.1% from $2,968 a year earlier but up 0.2% from the prior quarter.

Analysis

Vyome Holdings (HIND) Depreciation & Amortization (CF) (2015 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Vyome Holdings reported Depreciation & Amortization (CF) of $10,709, down 27.6% year-over-year; for FY2025, it came in at $11,985, down 30.9% from FY2024.

  • Depreciation & Amortization (CF) has declined in each of the last three years, with a five-year compound annual growth rate of -48.8% (FY2020 to FY2025).
  • Going back by year, Depreciation & Amortization (CF) was $17,347 in FY2024 (-85.7%), $121,000 in FY2023 (-63.3%), $330,000 in FY2022 (+42.2%) and $232,000 in FY2021 (-31.8%).
  • The five-year range for quarterly Depreciation & Amortization (CF) is $2,605 (Q1 2026) to $100,000 (Q4 2021).
  • Year-over-year, Depreciation & Amortization (CF) has declined for 16 consecutive quarters, with an average decline of 41.3% over the last eight quarters.
  • The fastest year-over-year change in Depreciation & Amortization (CF) over five years came in Q2 2022 (growth of 172.7%), and the weakest in Q3 2024 (a decline of 88.6%).
  • Business Quant data shows HIND's Depreciation & Amortization (CF) at $2,605 (Q1 2026), $2,688 (Q4 2025) and $2,806 (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 1.96 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 194.00 Mn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 599.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 1.93 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 1.11 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 98.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 1.62 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 56.50 Mn
10 Vyome Holdings 13.55 Mn -12.56 Mn 11,658.00 2,610.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2,610.00
Mar 31, 2026 2,605.00
Dec 31, 2025 2,688.00
Sep 30, 2025 2,806.00
Jun 30, 2025 2,968.00
Mar 31, 2025 3,523.00
Dec 31, 2024 3,864.00
Sep 30, 2024 4,427.00
Jun 30, 2024 6,000.00
Mar 31, 2024 6,000.00
Dec 31, 2023 7,000.00
Sep 30, 2023 39,000.00
Jun 30, 2023 38,000.00
Mar 31, 2023 37,000.00
Dec 31, 2022 59,000.00
Sep 30, 2022 87,000.00
Jun 30, 2022 90,000.00
Mar 31, 2022 94,000.00
Dec 31, 2021 100,000.00
Sep 30, 2021 92,000.00
API Access

Vyome Holdings Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=HIND&period=max&api_key=YOUR_API_KEY